findmyKOL
Clinical trialNCT01251536CompletedPhase 2Interventional

Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer

SponsorUniversitaire Ziekenhuizen KU LeuvenEnrollment108Colorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Universitätsklinik Für Innere Medizin, Klinishe Abteilung Für Hämatologie Und Onkologie

    Innsbruck, Austria

  • Lkh Leoben, Abteilung F. Innere Medizin

    Leoben, Austria

  • Akh Linz, Innere Medizin 3, Zentrum Für Hämatologie Und Medizinishe Onkologie

    Linz, Austria

  • Landeskrankenhaus Salzburg, Univ. Klinik Für Innere Medizin Iii, Universitätsklinikum Der Pmu

    Salzburg, Austria

  • Krankenanstalt Rudolfstiftung, 1 Medizinishe Abteilung

    Vienna, Austria

  • St Vincent Krankenhaus Betriebs Gmbh

    Zams, Austria

Belgium
  • Imelda Ziekenhuis

    Bonheiden, Belgium

  • Cliniques Universitaires St Luc

    Brussels, Belgium

  • Erasme Hospital

    Brussels, Belgium

  • Az Middelares Gent

    Ghent, Belgium

  • Uz Gent

    Ghent, Belgium

  • Centre Hospitalier de Jolimont-Lobbes, Oncology Médicale

    Haine-Saint-Paul, Belgium

  • Az Groeninge

    Kortrijk, Belgium

  • Uz Gasthuisberg

    Leuven, Belgium

  • Chc Saint Joseph

    Liège, Belgium

  • Az Sint Maarten Mechelen/duffel

    Mechelen, Belgium

  • H. Hartziekenhuis

    Roeselare, Belgium

  • Az Turnhout (campus St Elisabeth)

    Turnhout, Belgium

France
  • Hôpital Avicennes

    Bobigny, France

  • Hôpital Saint-André

    Bordeaux, France

  • Hopital Européen Georges Pompidou

    Paris, France

  • Centre Eugène Marquis

    Rennes, France

  • Chu Charles Nicolle

    Rouen, France

Hungary
  • Medical Center of the University of Pecs , National Institute Oncology

    Budapest, Hungary

  • State Health Center

    Budapest, Hungary

Spain
  • Hospital Universitari Vall D'Hebron

    Barcelona, Spain

  • Institut Català D'Oncologia

    Barcelona, Spain

  • Hospital Universitario Marqués de Valdecilla

    Santander, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Spain

  • Hospital Clinico Universitario de Valencia

    Valencia, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Dose escalation of cetuximabStandard first line treatment with cetuximab + Folfiri
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2010
Primary completion
30 Jun 2016
Completion
31 Jul 2019
Last update posted
11 Oct 2019
Registered enrollment
108
Registry id
NCT01251536

Cross-registrations

EU-CTR / CTIS (EudraCT)2009-009992-36

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.